Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic PropertiesMatthew D. Hill, Andrew P. Degnan, Derek Norris et al.|ACS Medicinal Chemistry Letters|2022Cited by 10